US FDA user-fee reauthorization legislation is proceeding through Congress, most recently with a May 11 markup in the Senate Health, Education, Labor and Pensions Committee, and lawmakers want a bill passed by July.
But it has already been almost nine months since FDA and industry trade groups completed negotiations on the underlying agreement...